Skip to main content
logo
CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.6600
-0.0100 (-1.49%)
At close: Mar 27, 2026

HKG:0775 Revenue

In the year 2025, CK Life Sciences Int'l., (Holdings) had annual revenue of 5.41B HKD, down -2.04%. CK Life Sciences Int'l., (Holdings) had revenue of 2.80B in the half year ending December 31, 2025, with 2.22% growth.

Revenue
5.41B
Revenue Growth
-2.04%
P/S Ratio
1.17
Revenue / Employee
2.82M
Employees
1,920
Market Cap
6.34B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.41B-112.45M-2.04%
Dec 31, 20245.52B199.94M3.76%
Dec 31, 20235.32B47.14M0.89%
Dec 31, 20225.28B-126.72M-2.35%
Dec 31, 20215.40B459.77M9.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Shanghai Haohai Biological Technology2.75B
Lepu Biopharma1.04B
Alphamab Oncology861.24M
Abbisko Cayman681.17M
Ocumension Therapeutics595.79M
CStone Pharmaceuticals221.89M
Guangzhou Innogen Pharmaceutical Group146.34M
CARsgen Therapeutics Holdings139.84M
Revenue Rankings

CK Life Sciences Int'l., (Holdings) News

More News